Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE (0.24%), DAX (0.56%), CAC40 (0.53%)

Oct 07 ,2026

  • Synopsis

    • European equity markets are set for a negative open amidst mostly lower Asian equities Wednesday. Hong Kong, Japan and South Korea underperforming with AI trade under some pressure. Mainland China remains closed for National Day. S&P 500 futures flat.

    • Oil strengthening following period of stabilization as tracking data highlights rebound in Middle East crude flows. However, reports also highlighting renewed Iranian attacks on tankers transiting Strait of Hormuz and stepped up fighting in Yemen. Oil strength corresponding with upward move in bond yields. Follows overnight rate pullback tabbed in part to Le Pen spending cut promise, though euro and French OAT futures have resumed declines.

    • Norway's finance minister Stoltenberg presents the state budget for 2027 in parliament at 10:00CET, related press conf at 13:00. EU's Hansen participates in a debate in the French Assemblée Nationale and EU's von der Leyen participates in the Summit of Southern European Union countries (MED-9) where French President Macron is also due to attend. EU's Albuquerque speech at the BusinessEurope and European Banking Federation joint event. Chancellor Merz speech/panellist at event for the 80th Anniversary of Handelsblatt and the 100th Anniversary of WirtschaftsWoche.

    • In central banks, Iceland interest rate decision at 9:30BST. No change expected in 8.0% benchmark interest rate. Poland central bank is expected to leave its benchmark interest rate unchanged at 3.75% with its announcement at 15:00CET whilst Hungary central bank minutes of last MPC meeting. ECB's Cipollone panellist at 7:00CET at event organised by the Central Bank of the Philippines. ECB's Vujčić speech at 9:20CET at the event "The European Commission Bank Competitiveness Report: A Dialogue between EU Policy Makers and the Private Sector". Digital Asset Week London sees BOE's Mills speech at 9:40BST, panellist at 10:00. Denmark central bank's Nødgaard speech at 10:00CET at the Danish Economic Society, Aarhus Univ.

    • Macro data include, Germany Aug industrial production, France Aug trade balance, Sweden Sep preliminary CPI, Norway Aug manufacturing production, UK Sep house price index - Lloyds

    • A light corporate news includes ABN AMRO (ABN.NA), as NLFI announced a fifth trading plan to further reduce its stake whilst Repsol (REP.SM) reported Q3 upstream production of 574 Kboe/d vs 551 Kboe/d y/y.

  • Politics/Macro/World News

    • Brussels Looks To Capture Big Tech Through Tax On Large Corporations - FT

    • Healey warns banks that UK faces 'challenging' fiscal picture but stays tight-lipped on tax - FT

  • Top company news

    • Earnings/updates

      • France:

        • GDS.FP (Ramsay Générale de Santé) -- reports FY net income (€48.3M) vs year-ago (€54.1M)

      • Nordics:

        • CLAS.B.SS (Clas Ohlson) -- reports Sep sales SEK1.12B; +12% y/y organic growth

        • GIGA.NO (Gigante Salmon) -- Q3 Operational Update: No fish were harvested during the quarter

      • Southern Europe:

        • REP.SM (Repsol) -- Trading Statement: Q3 total upstream production 574 Kboe/d vs year-ago 551 Kboe/d

    • M&A

      • TFIN.IM (Trevi-Finanziaria Industriale) -- I.CO.P files a complaint with CONSOB regarding Webuild's communications concerning the offer for Trevi-Finanziaria Industriale

      • ABN.NA (ABN AMRO) -- NLFI announces fifth trading plan to further reduce stake in ABN AMRO

      • EVK.GR (Evonik Industries) -- SPD in North Rhine-Westphalia urging state premier Hendrik Wüst to support independence of Evonik amid takeover interest from BASF -- Manager magazine

      • ACA.FP (Credit Agricole) -- CACEIS and Edmond de Rothschild expand their Asset Servicing partnership in Luxembourg

    • Healthcare

      • GRF.SM (Grifols) -- FDA notes increased reports of allergic/hypersensitivity with one lot of Yimmugo

      • NRIX (Nurix Therapeutics) -- enrolls first patient in NX-5948-203 study of bexobrutideg

      • 4568.JP (Daiichi Sankyo) -- NICE recommends Daiichi Sankyo's Enhertu to treat HER2-low metastatic or unresectable breast cancer after chemotherapy

    • Other

      • IP.IM (Interpump Group) -- announces Riccardo Mastronardi is no longer an executive with strategic responsibilities at the company

      • ALSEN.FP (Sensorion) -- CFO Laurene Danon has decided to step down to pursue new opportunities

      • IEG.IM (Italian Exhibition Group) -- places 1.0M shares (0.9M on behalf of holder) at €13.26/share

      • NDX1.GR (Nordex Group) -- records 389 MW of new orders in Türkiye; names of the customers and projects are not disclosed

      • CAP.FP (Capgemini) -- announces share buyback authorization to neutralize dilution from ESOP plan

      • FRVIA.FP (Forvia) -- enters JV agreement with Anand Group to accelerate seating growth in India

      • AVOL.SW (Avolta) -- Avolta's Hudson secures new 20-year duty-free contract at Seattle-Tacoma International

      • GF.SW (Georg Fischer) -- GF proposes Ton Büchner to succeed Yves Serra as Chairman at the upcoming AGM in April 2027

      • 8S30.GR (Sphere 3D) -- SEC filing: SCHEDULE 13D (Filed by Block Joel M)

      • AVIO.IM (Avio) -- USA breaks ground on first U.S. solid rocket motor facility in Virginia; now expected to be completed by late FY28, production in early FY29

      • OKX Hong Kong FinTech raises undisclosed round at $25B pre-money valuation (pre-open)

  • Key rating changes

    • Upgrades

      • RKT.LN (Reckitt Benckiser) -- buy from neutral at Goldman Sachs

      • SKA.B.SS (Skanska) -- buy from hold at SEB

      • SAVE.SS (Nordnet) -- buy from hold at ABG Sundal Collier

      • MRO.LN (Melrose Industries) --neutral from underperform at BNP Paribas Exane

      • VLTSA.FP (Voltalia) --equal-weight from underweight at Morgan Stanley

    • Downgrades

      • BESI.NA (BE Semiconductor Industries) -- sell from buy at UBS

      • ENI.IM (Eni) -- neutral from outperform at BNP Paribas Exane

      • PPGN.SW (PolyPeptide Group) -- to neutral from buy at UBS

      • INCH.LN (Inchcape) -- neutral from buy at UBS

    • Initiations

      • NKR.NO (Nekkar) -- buy at Pareto

  • Data

    • Nikkei (0.51%) to 70323.95

    • Hang Seng (0.60%) to 24134.67

    • Shanghai Composite +0.00% to 3842.19

    • S&P futures +4.3 vs prior close of 7874.0

    • €-$ (0.0028) or (0.25%) to 1.1232

    • $-¥ +0.27 or +0.17% to 158.38

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.